Increasing incidence of cholangiocarcinoma in Crete 1992-2000

Anticancer Research

Volumn 22, Issue 6 B, 2002, Pages 3637-3641

  Mouzas, Ioannis A ^a   Dimoulios, Philippos ^b   Vlachonikolis, Ioannis G ^b   Skordilis, Panagiotis ^b   Zoras, Odysseus ^b   Kouroumalis, Elias ^b  

^a UNIVERSITY OF CRETE   (Greece)

^b NONE

Author keywords

Cholangiocarcinoma; Epidemiology

Indexed keywords

AGE DISTRIBUTION; ARTICLE; BILE DUCT CARCINOMA; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; FEMALE; GEOGRAPHIC DISTRIBUTION; GREECE; HUMAN; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICS; SURVIVAL RATE; TUMOR LOCALIZATION;

BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; FEMALE; GREECE; HUMANS; INCIDENCE; MALE; SURVIVAL RATE;

EID: 0036875155     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Parkin DM, Ohshima H, Srivatanakul P and Vatanasapt V: Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention. Cancer Epidemiol Biomarkers Prev 2: 537-544, 1993.
2. Kuper H, Lagiou P, Mucci LA, Tamimi R, Benetou V and Trichopoulos D: Risk factors for cholangiocarcinoma in a low risk Caucasian population. Soz Praventivmed 46: 182-185, 2001.
3. Srivatanakul P, Ohshima H, Khlat M, Parkin M, Sukaryodhin S, Brouet I and Bartsch H: Opisthorchis viverrini infestation and endogenous nitrosamines as risk factors for cholangiocarcinoma in Thailand. Int J Cancer 48: 821-825, 1991.
4. Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P and Brechot C: Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group. Ann Intern Med 122: 161-168, 1995.
5. El Serag HB and Mason AC: Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340: 745-750, 1999.
6. El Serag HB and Mason AC: Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med 160: 3227-3230, 2000.
7. Taylor-Robinson SD, Thomas HC, Arora S and Hargreaves S: Increased mortality from liver cancer in England and Wales is not related to hepatitis C. BMJ 319: 640, 1999.
8. Kato I, Kuroishi T and Tominaga S: Descriptive epidemiology of subsites of cancers of the liver, biliary tract and pancreas in Japan. Jpn J Clin Oncol 20: 232-237, 1990.
9. Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S and Thomas HC: Increase in primary liver cancer in the UK, 1979-94. Lancet 350: 1142-1143, 1997.
10. Patel T: Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33: 1353-1357, 2001.
11. Taylor-Robinson SD, Toledano MB, Arora S, Keegan TJ, Hargreaves S, Beck A, Khan SA, Elliott P and Thomas HC: Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut 48: 816-820, 2001.
12. Mouzas IA, Skordilis P, Frangiadakis N, Leondidis C, Alexandrakis G, Potamianos S, Kouroumalis E and Manousos ON: Carcinoma of the ampulla of Vater in Crete. A clinical and ERCP registry over eight years. Anticancer Res 19: 4501-4505, 1999.
13. Lindholm LH, Koutis AD, Lionis CD, Vlachonikolis IG, Isacsson A and Fioretos M: Risk factors for ischaemic heart disease in a Greek population. A cross-sectional study of men and women living in the village of Spili in Crete. Eur Heart J 13: 291-298, 1992.
14. Lindholm LH, Jern S, Lionis CD, Koutis AD, Jakobsson A, Isacsson A, Slaug B and Fioretos M: Electrocardiographic signs of coronary heart disease in a "low risk" population in rural Crete. Coron Artery Dis 4: 427-435, 1993.
15. Aravanis C, Mensink RP, Corcondilas A, Ioanidis P, Feskens EJ and Katan MB: Risk factors for coronary heart disease in middle-aged men in Crete in 1982. Int J Epidemiol 17: 779-783, 1988.
16. Armitage P and Berry G: Statistical Methods in Medical Research. (ed 2nd). Oxford, Blackwell Scientific Publications, 1987.
17. Vlachonikolis IG, Mavromanolakis M and Georgoulias V: Descriptive epidemiology of cancer in Crete, Greece, 1994: Part II; Gastrointestinal cancers. Journal of Balkan Union of Oncology (BUON) 4: 73-81, 1999.
18. de Groen PC, Gores GJ, LaRusso NF, Gunderson LL and Nagorney DM: Biliary tract cancers. N Engl J Med 341: 1378, 1999.
19. Fausa O, Schrumpf E and Elgjo K: Relationship of inflammatory bowel disease and primary sclerosing cholangitis. Semin Liver Dis 11: 31-39, 1991.
20. Takikawa H and Manabe T: Primary sclerosing cholangitis in Japan - analysis of 192 cases. J Gastroenterol 32: 134-137, 1997.
21. Okada H, Mizuno M, Yamamoto K and Tsuji T: Primary sclerosing cholangitis in Japanese patients: association with inflammatory bowel disease. Acta Med Okayama 50: 227-235, 1996.
22. Okolicsanyi L, Fabris L, Viaggi S, Carulli N, Podda M and Ricci G: Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group. Eur J Gastroenterol Hepatol 8: 685-691, 1996.
23. Schrumpf E, Abdelnoor M, Fausa O, Elgjo K, Jenssen E and Kolmannskog F: Risk factors in primary sclerosing cholangitis. J Hepatol 21: 1061-1066, 1994.
24. Torok N and Gores GJ: Cholangiocarcinoma. Semin Gastrointest Dis 12: 125-132, 2001.
25. Narayanan Menon KV and Wiesner RH: Etiology and natural history of primary sclerosing cholangitis. J Hepatobiliary Pancreat Surg 6: 343-351, 1999.
26. Manousos ON, Giannadaki E, Mouzas IA, Tzardi M, Koutroubakis I, Skordilis P, Vassilakis S, Kouroumalis E and Vlachonikolis IG: Ulcerative colitis is as common in Crete as in northern Europe: a 5-year prospective study. Eur J Gastroenterol Hepatol 8: 893-898, 1996.
27. Srivatanakul P, Parkin DM, Jiang YZ, Khlat M, Kao-Ian UT, Sontipong S and Wild C: The role of infection by Opisthorchis viverrini, hepatitis B virus, and aflatoxin exposure in the etiology of liver cancer in Thailand. A correlation study. Cancer 68: 2411-2417, 1991.
28. Sorensen HT, Friis S, Olsen JH, Thulstrup AM, Mellemkjaer L, Linet M, Trichopoulos D, Vilstrup H and Olsen J: Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark. Hepatology 28: 921-925, 1998.
29. Kobayashi M, Ikeda K, Saitoh S, Suzuki F, Tsubota A, Suzuki Y, Arase Y, Murashima N, Chayama K and Kumada H: Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis. Cancer 88: 2471-2477, 2000.
30. Lionis C, Vlachonikolis IG, Skliros S, Symeonidis A, Merkouris BP and Kouroumalis E: Do undefined sources of hepatitis C transmission exist? The Greek study in General Practice. J Viral Hepat 7: 218-224, 2000.
31. Patel T: Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33: 1353-1357, 2001.
32. Su WC, Chan KK, Lin XZ, Lin PW, Chow NH, Shin JS, Chen CY and Tsao CJ: A clinical study of 130 patients with biliary tract cancers and periampullary tumors. Oncology 53: 488-493, 1996.
33. Price P: Cholangiocarcinoma and the role of radiation and chemotherapy. Hepatogastroenterology 48: 51-52, 2001.
34. Ahrendt SA, Nakeeb A and Pitt HA: Cholangiocarcinoma. Clin Liver Dis 5: 191-218, 2001.
35. Uenishi T, Hirohashi K, Kubo S, Yamamoto T, Yamazaki O and Kinoshita H: Clinicopathological factors predicting outcome after resection of mass-forming intrahepatic cholangiocarcinoma. Br J Surg 88: 969-974, 2001.
36. Yamamoto M, Takasaki K, Otsubo T, Katsuragawa H and Katagiri S: Recurrence after surgical resection of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 8: 154-157, 2001.